Regulation & law · 21/04/2022Updated: 10/17/2026 · 1 min read
Federal Trade Commission Approves Pfizer's Acquisition of BioNTech, Following Review of Proposed Transaction
Summary
The Federal Trade Commission has approved Pfizer's acquisition of BioNTech, following a review of the proposed transaction, which is expected to close in the first half of 2024, subject to certain conditions
Original source language: Federal Register — Justice DepartmentOpen original release →